Charles River Laboratories (CRL)

Operating return on assets (Operating ROA)

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Operating income (ttm)	US$ in thousands	617,261	648,149	647,623	670,089	650,975	659,972	664,798	614,937	589,862	545,982	522,933	462,151	432,729	412,591	372,640	375,640	351,151	344,844	336,404	333,346
Total assets	US$ in thousands	8,195,000	7,607,010	7,772,380	7,699,440	7,602,770	7,382,770	7,529,360	7,075,050	7,024,290	7,058,440	6,720,350	5,808,960	5,490,830	5,213,340	5,240,880	5,201,790	4,692,790	4,582,560	4,625,480	3,926,640
Operating ROA		7.53%	8.52%	8.33%	8.70%	8.56%	8.94%	8.83%	8.69%	8.40%	7.74%	7.78%	7.96%	7.88%	7.91%	7.11%	7.22%	7.48%	7.53%	7.27%	8.49%

December 31, 2023 calculation

Operating ROA = Operating income (ttm) ÷ Total assets
= $617,261K ÷ $8,195,000K
= 7.53%

Charles River Laboratories has shown a relatively stable trend in its operating return on assets (ROA) over the past five quarters, ranging from 7.11% to 8.94%. The operating ROA measures the company's efficiency in generating operating profits from its total assets.

The operating ROA has been consistently above 7% throughout the analyzed periods, indicating that the company is effectively utilizing its assets to generate operating income. Additionally, the operating ROA has not shown any significant fluctuations, suggesting a level of consistency in the company's operational efficiency.

Overall, Charles River Laboratories' operating ROA performance indicates that the company is effectively managing its assets to generate operating profits, which is a positive indicator for investors and stakeholders.